Log In
Print
BCIQ
Print
Print this Print this
 

GV1001

  Manage Alerts
Collapse Summary General Information
Company GemVax & Kael Co. Ltd.
DescriptionCancer vaccine targeting human telomerase reverse transcriptase (hTERT)
Molecular Target Telomerase
Mechanism of ActionVaccine; Telomerase inhibitor
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today